Trump Administration Archives - Page 47 of 63

Podcast: KHN’s ‘What The Health?’ The Karma Of Cutting Medicare

Stephanie Armour of The Wall Street Journal, Alice Ollstein of Politico and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss the suggested cuts to health programs in President Donald Trump’s budget proposal, the latest on lawsuits challenging work requirements for Medicaid enrollees and the FDA’s crackdown on e-cigarettes. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.

March 15, 2019

Neglect Unchecked

Nursing Home Fines Drop As Trump Administration Heeds Industry Complaints

Inspectors are citing nursing facilities for violating health and safety more often than during the Obama administration. But the average fine is nearly a third lower than it was before President Donald Trump took office.

By Jordan Rau

March 15, 2019

Judge Vows To Rule On Medicaid Work Requirements By End Of March

A federal district judge appeared skeptical of the arguments by the Justice Department and Arkansas and Kentucky that their programs should mandate that some enrollees work.

By Phil Galewitz

March 14, 2019

Trump’s Budget Offers $291M To Fight HIV In U.S. But Trims Overseas Efforts

The budget would increase funding for efforts like the state-centered initiatives run by the Centers for Disease Control and the Ryan White Program, which offers services and treatment to patients. But it would also dramatically cut funding for global HIV efforts.

By Carmen Heredia Rodriguez

March 12, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

March 8, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

March 1, 2019

Podcast: KHN’s ‘What The Health?’ ‘Medicare-For-All’ Debate: Who’s Going To Pay

Margot Sanger-Katz of The New York Times, Paige Winfield Cunningham of The Washington Post and Jennifer Haberkorn of the Los Angeles Times join KHN’s Julie Rovner to discuss the new “Medicare-for-all” bill introduced by House Democrats, the grilling of pharmaceutical company CEOs by a Senate committee and new Trump administration rules that take aim at Planned Parenthood. Plus, Rovner interviews KHN’s Julie Appleby about the latest “Bill of the Month” installment.

Feb. 28, 2019

Despite 1991 Ruling, Foes Of New Family Planning Rules See Law On Their Side

Lawyers seeking to block the Trump administration’s decision to alter rules for the Title X family planning program say their efforts will not be stymied by the Supreme Court’s approval of similar rules 28 years ago. They point to new protections enacted in the Affordable Care Act and language in funding bills that shifts the legal calculus.

By Julie Rovner

Feb. 28, 2019

In Florida, Drug Importation From Canada Finds New Champions, Old Snags

The state’s governor said the plan has the full support of the White House. But the Trump administration was noncommittal about whether allowing states to buy and import cheaper drugs from up north could be the answer to the nation’s drug-pricing problem.

By Shefali Luthra and Phil Galewitz

Feb. 25, 2019

HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program

The new regulation would drop previous rules for the Title X program requiring that women with unintended pregnancies be told about all options, including abortion. It would also mandate that organizations separate facilities providing federally funded services from those providing abortions.

By Julie Rovner

Feb. 22, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Feb. 22, 2019

Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?

Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the latest national health spending estimates, another FDA crackdown on dietary supplements and lawsuits between insurers and the federal government that could result in a windfall for consumers.

Feb. 21, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Feb. 15, 2019

Utah’s Novel Plan For Medicaid Expansion Opens Door To Spending Caps Sought By GOP

Utah’s proposal to limit federal and state funding on Medicaid is a radical change. Anti-poverty advocates are concerned that caps could limit how many people are enrolled and restrict services. They also worry other states would adopt a similar plan.

By Phil Galewitz

Feb. 14, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.

By Brianna Labuskes

Feb. 8, 2019

Trump’s Pediatric Cancer Crusade A Drop In Bucket Compared With Past Presidential Pitches

President Donald Trump wants Congress to allot $500 million over 10 years for pediatric cancer research. While it’s welcomed by researchers and advocates, it’s not a lot of money.

By Victoria Knight

Feb. 8, 2019

Podcast: KHN’s ‘What The Health?’ A ‘Healthy’ State Of The Union

Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.

Feb. 7, 2019

Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale

President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven’t reached the market.

By Sydney Lupkin and Jay Hancock

Feb. 7, 2019

Trump Pledges To End HIV Transmission By 2030. Doable, But Daunting.

The president’s promise to eliminate HIV transmission within 10 years is a goal long sought by advocates, but it won’t be an easy undertaking.

By Carmen Heredia Rodriguez

Feb. 6, 2019

Trump Highlights Health Agenda With Vow To Lower ‘Unfair’ Drug Prices

The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.

By Julie Rovner

Feb. 6, 2019

�Թϲ��

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Trump Administration